Smoking Study Statistics

Demographics

• Average participant Age: 43
• Average lung age at start of program: 44.5
• Average amount smoked daily: 17 cigarettes / day
• Average age started smoking: 16.7
• Percent of patients who made a past quit attempt: 100%
• Number that had tried a SmokeStik electronic cigarette: none
• Number that had CBT: none
• Number that had PFT / Lung age: none
• Number that had Varenicline: one

Participant Results

• All but one quit in the first 4 weeks.
• All were quit by the end of the 12 week program
• Average Lung age at end of program: 36.2 (improvement of 8.3 years)
• Qualitative self-report found SmokeStik electronic cigarette averaged to be helpful in 95% of participants smoking cessation
• Qualitative self-report indicated the majority of participants found SmokeStik electronic cigarettes easy to use
• Qualitative self-report indicated that majority of participants enjoyed the synthetic smoke feature (propylene glycol) in SmokeStik electronic cigarettes
• Negative blood levels of propylene glycol at 3 points in study
• No significant mood disturbance on BDI (Becks Depression Inventory)

Study Results:

• Multi-modal therapy was well received by the pilot group
• SmokeStik electronic cigarette appears safe and effective
• No appreciable side effects of Varenicline.